ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 614,33
0,56%
Dow Jones
38 778,10
0,00%
DAX
18 098,26
0,14%
Brent Oil
83,95
0,06%
Bitcoin
65 083,13
-2,11%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Momenta Pharmaceuticals Inc (MNTA)

  7. Momenta Pharmaceuticals Inc (MNTA) Actualités

MNTA

Momenta Pharmaceuticals (MNTA)

Momenta Pharmaceuticals Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:MNTA
DateHeureSourceTitreSymboleSociété
10/11/202016h28Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:MNTAMomenta Pharmaceuticals Inc
13/10/202014h15Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(g) (15-12g)NASDAQ:MNTAMomenta Pharmaceuticals Inc
01/10/202023h19Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:MNTAMomenta Pharmaceuticals Inc
01/10/202022h55Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:MNTAMomenta Pharmaceuticals Inc
01/10/202022h31Edgar (US Regulatory)Post-effective Amendment to an Automatic Shelf Registration of Form S-3asr or Form F-3asr (posasr)NASDAQ:MNTAMomenta Pharmaceuticals Inc
01/10/202022h21Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:MNTAMomenta Pharmaceuticals Inc
01/10/202015h55Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or ...NASDAQ:MNTAMomenta Pharmaceuticals Inc
01/10/202015h00Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:MNTAMomenta Pharmaceuticals Inc
01/10/202014h57Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:MNTAMomenta Pharmaceuticals Inc
01/10/202014h44GlobeNewswire Inc.Momenta Pharmaceuticals Announces Completion of Proposed Sale to Johnson & JohnsonNASDAQ:MNTAMomenta Pharmaceuticals Inc
25/09/202023h47PR Newswire (US)Chesapeake Utilities to Join S&P SmallCap 600NASDAQ:MNTAMomenta Pharmaceuticals Inc
15/09/202014h00GlobeNewswire Inc.Momenta Pharmaceuticals Announces Expiration of Hart-Scott-Rodino Waiting Period in Connection with Proposed Sale to Johnson ...NASDAQ:MNTAMomenta Pharmaceuticals Inc
02/09/202012h54Edgar (US Regulatory)Statement of Ownership: Solicitation (sc 14d9)NASDAQ:MNTAMomenta Pharmaceuticals Inc
20/08/202021h18Edgar (US Regulatory)Written Communication Relating to an Issuer or Third Party (sc To-c)NASDAQ:MNTAMomenta Pharmaceuticals Inc
20/08/202009h02Dow Jones NewsJ&J, Biotech Firm In $6.5 Billion Deal J&J Agrees to Buy Biotech Company -- WSJNASDAQ:MNTAMomenta Pharmaceuticals Inc
19/08/202022h26Edgar (US Regulatory)Written Communication by the Subject Company Relating to a Third Party Tender Offer (sc14d9c)NASDAQ:MNTAMomenta Pharmaceuticals Inc
19/08/202013h21Dow Jones NewsJohnson & Johnson to Buy Momenta Pharmaceuticals for $6.5 BillionNASDAQ:MNTAMomenta Pharmaceuticals Inc
19/08/202012h35GlobeNewswire Inc.Momenta Enters Definitive Agreement with Johnson & JohnsonNASDAQ:MNTAMomenta Pharmaceuticals Inc
10/08/202022h44Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:MNTAMomenta Pharmaceuticals Inc
10/08/202013h00GlobeNewswire Inc.Momenta Pharmaceuticals Reports Second Quarter 2020 Financial and Operating ResultsNASDAQ:MNTAMomenta Pharmaceuticals Inc
03/08/202013h30GlobeNewswire Inc.Momenta Pharmaceuticals Announces Date of Second Quarter 2020 Financial Results Conference Call and WebcastNASDAQ:MNTAMomenta Pharmaceuticals Inc
28/07/202013h15GlobeNewswire Inc.Momenta Pharmaceuticals Announces FDA Rare Pediatric Disease Designation for Nipocalimab in HDFNNASDAQ:MNTAMomenta Pharmaceuticals Inc
15/06/202013h05GlobeNewswire Inc.Momenta Pharmaceuticals Announces Positive Topline Data from Interim Analysis of Phase 2 Vivacity-MG Study of Nipocalimab (M2...NASDAQ:MNTAMomenta Pharmaceuticals Inc
07/05/202013h00GlobeNewswire Inc.Momenta Pharmaceuticals Reports First Quarter 2020 Financial and Operating ResultsNASDAQ:MNTAMomenta Pharmaceuticals Inc
06/05/202016h04Edgar (US Regulatory)Confidential Treatment Order (ct Order)NASDAQ:MNTAMomenta Pharmaceuticals Inc
24/04/202023h29Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:MNTAMomenta Pharmaceuticals Inc
23/04/202014h00GlobeNewswire Inc.Momenta Pharmaceuticals Announces Date of First Quarter 2020 Financial Results Conference Call and WebcastNASDAQ:MNTAMomenta Pharmaceuticals Inc
02/04/202013h30GlobeNewswire Inc.Momenta Provides Corporate Update Amid COVID-19 PandemicNASDAQ:MNTAMomenta Pharmaceuticals Inc
27/02/202022h35Edgar (US Regulatory)Annual Report (10-k)NASDAQ:MNTAMomenta Pharmaceuticals Inc
26/02/202013h00GlobeNewswire Inc.Momenta Pharmaceuticals Reports Fourth Quarter and Full Year 2019 Financial ResultsNASDAQ:MNTAMomenta Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:MNTA

Dernières Valeurs Consultées

TG
YW5
Giant Mining
BIT
JRUE
Exchange Traded Fund Jpm...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés